Le Travenues Technology (ixigo) delivered impressive financial performance in Q3FY26, demonstrating strong growth momentum across its travel platform ecosystem. The company's board approved the quarterly results at a meeting held on January 22, 2026.

Strong Revenue Growth Across All Segments

The company reported robust consolidated revenue growth of 31.36% year-on-year, reaching ₹3,175.64 crores in Q3FY26 compared to ₹2,417.61 crores in Q3FY25. This performance was driven by strong growth across all business segments.

Profitability Metrics Show Strong Performance

The company's profitability metrics demonstrated significant improvement during the quarter. Net profit for Q3FY26 surged 54.17% to ₹239.51 crores from ₹155.40 crores in the corresponding quarter of the previous year.

Nine-Month Performance Overview

For the nine months ended December 31, 2025, the company maintained strong revenue momentum with consolidated revenue reaching ₹9,147.77 crores, representing a growth of 45.17% compared to ₹6,301.09 crores in the corresponding period of FY25. However, net profit for the nine-month period was ₹394.31 crores compared to ₹434.81 crores in the previous year.

Major Corporate Developments

The company completed several significant corporate actions during the quarter:

Preferential Allotment: ixigo raised ₹12,955.63 crores through preferential allotment of 4,62,70,092 equity shares to MIH Investments One B.V. at ₹280 per share on November 12, 2025.

Employee Stock Options: The company allotted 492,119 equity shares under various ESOS schemes, increasing the paid-up share capital from ₹437.58 crores to ₹438.07 crores.

Earnings Per Share Performance

The company's earnings per share showed positive momentum with basic EPS at ₹0.58 for Q3FY26 compared to ₹0.40 in Q3FY25. For the nine-month period, basic EPS stood at ₹1.00 compared to ₹1.13 in the corresponding period of the previous year.

Exceptional Items Impact

The company recorded exceptional items of ₹27.96 crores during Q3FY26, primarily related to increased employee benefit liabilities arising from the implementation of new Labour Codes notified by the Government of India on November 21, 2025.

IPO Proceeds Utilization

The company continued to deploy its IPO proceeds of ₹1,126.71 crores raised in FY25, with ₹935.18 crores utilized as of December 31, 2025, primarily for working capital requirements, cloud infrastructure investments, and strategic initiatives.

Le Travenues Technology Limited has announced the grant of 98,944 stock options under its employee stock option schemes, following approval by the Nomination and Remuneration Committee on January 22, 2026. The grant covers three distinct schemes and represents a significant employee incentive initiative by the travel technology company.

Stock Option Grant Details

The committee approved the grant across three employee stock option schemes with specific allocations and terms:

Pricing and Exercise Terms

The options have been granted at an exercise price of ₹93.00 per option. The exercise period for all granted options shall be five years from the date of respective vesting of each option, beyond which the options would lapse. In case of employee resignation, vested options can be exercised within 365 days from the last working day with the company.

Scheme Objectives and Structure

The employee stock option schemes are designed with multiple strategic objectives:

• Motivate and retain talented employees to contribute towards overall growth and profitability
• Provide means to attract and retain appropriate human talent
• Achieve sustained growth and shareholder value creation by aligning employee interests with long-term company interests
• Create ownership sense and participation amongst employees
• Provide additional deferred rewards to employees

Regulatory Compliance

The announcement was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schemes operate in accordance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The Nomination and Remuneration Committee meeting was conducted from 02:15 P.M. to 02:30 P.M. (IST) on January 22, 2026.

Share Conversion Impact

Upon vesting and exercise, the granted options will be converted into an equivalent number of equity shares on a pari passu basis with the existing equity shares of the company. The total of 98,944 options represents the potential for equivalent equity share creation, subject to vesting conditions and employee exercise decisions.